Comparative Study Between Using WHO Labour Care Guide & Modified WHO Partograph
Launched by HEND MAHMOUD ABDELGHANY · Jul 31, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods for monitoring labor in first-time mothers: a modified version of the WHO partograph and the new WHO labour care guide. Both tools are used to help healthcare providers track the progress of labor and ensure the safety of mothers and their babies. The goal is to see which method is more effective in managing labor for women who are 37 weeks or more pregnant and are experiencing their first childbirth.
To participate in this study, women must be between the ages of 18 and 35, have a body mass index (BMI) between 18.5 and 29.9, and be in the active first stage of labor with their baby in the head-down position. However, women with certain health issues or complications related to pregnancy cannot join the study. If you decide to participate, you will be assigned randomly to one of the two monitoring methods and will be closely observed during your labor to help researchers understand which method works best. This trial is currently recruiting participants, and your involvement could help improve care for future mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Primiparous women.
- • Term gestation between 37 and 40 weeks.
- • Maternal age from 18 -35 years
- • Body mass index BMI of 18.5 to 29.9 kg/m2
- • Cephalic presentation. 6. Active first stage of labour
- Exclusion Criteria:
- • Women with any medical comorbidities, such as (hypertension, diabetes mellitus, renal disease, or pulmonary disease).
- • Women with presence of any obstetrical complications, such as preterm birth, multiple gestation, breech presentation, postdated pregnancy, or bad obstetrical history.
- • women who were given intrapartum epidural analgesia.
About Hend Mahmoud Abdelghany
Hend Mahmoud Abdelghany is a dedicated clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With a robust background in clinical study design and implementation, she is committed to conducting innovative trials that adhere to the highest ethical standards and regulatory compliance. Her expertise spans various therapeutic areas, fostering collaboration among multidisciplinary teams to ensure the successful execution of studies. Through her leadership, she aims to contribute significantly to the development of effective treatments and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Old Cairo, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported